ACTIVE

PHARMACIE SMITS

Export PDF

Financial year 2025 · Closed on 31/12/2025

Net result-159,3 k €-238,0 %over 1 year
Gross margin373,6 k €-41,5 %over 1 year
Equity260,4 k €-38,0 %over 1 year
Workforce8,2 ETP-9,9 %over 1 year

Identity

Source · BCE/KBO

PHARMACIE SMITS is a Public limited company incorporated in 2004. Its main activity is: Manufacture of pharmaceutical preparations. Its registered office is in Wavre. It employs on average 8,2 ETP workers (FTE).

Legal situation
Normal situation
BCE/KBO no. / VAT
BE 0870.643.789
Incorporation
17/12/2004
Legal form
Public limited company
Registered office
Place Cardinal Mercier 4
1300 Wavre · WallonieSee on map
Contributed capital
250 000,00 €
Latest accounts
31/12/2025
Average workforce
8,2 ETP
Joint committees (1)
  • 313
Signals
Healthy social debts

Financials

Source · NBB, 20 filings

Trend over 20 financial years

20252024202320222021
Income statement
Gross margin373,6 k €638,2 k €466,3 k €598,7 k €827,1 k €
EBITDA-54,8 k €207,7 k €-16,3 k €151,6 k €287,7 k €
Operating result-110,1 k €182 k €-34,5 k €107,4 k €246,8 k €
Net result-159,3 k €115,4 k €-75,1 k €51,7 k €158,4 k €
Balance sheet
Equity260,4 k €419,6 k €304,2 k €379,3 k €377,6 k €
Total assets1,9 M €1,9 M €2,1 M €2,2 M €2,4 M €
Cash29,9 k €51 k €81 k €42,8 k €119,4 k €
Debts1,6 M €1,5 M €1,8 M €1,8 M €2 M €
Other
Workforce8,2 ETP9,1 ETP8,6 ETP8,1 ETP11,8 ETP

Valuation

Indicative valuation

As an indication, this company is worth

between 0 € and 100 k€
See the valuation

Board of directors

Source · NBB, accounts to 31/12/2025

1 active · 11 ended

Active mandates

HG Pharma

Managing director · since 07 juillet 2023 · until 07 juillet 2029 · 0832.287.120

Represented by GILLES SMITS

Active

Ended mandates

JEAN-JACQUES SMITS

Managing director · since 07 juin 2023 · until 07 juin 2029

Ended
JEAN-JACQUES SMITS

Managing director · since 01 janvier 2017 · until 01 janvier 2023

Ended
HG Pharma

Managing director · since 01 janvier 2011 · until 01 janvier 2017 · 0832.287.120

Represented by GILLES SMITS

Ended
HG Pharma

Managing director · since 01 janvier 2011 · until 01 janvier 2017 · 0832.287.120

Represented by GILLES SMITS

Ended

Other companies at this address

Place Cardinal Mercier 4 1300 Wavre
CompanyCBE no.
Wavrienne de Gestion Immobilière● Active
0446.490.406

Full financial information

Source · NBB
202520242023202220212020
Type of accountAbridged modelAbridged modelAbridged modelAbridged modelAbridged modelAbridged model
Start of the financial year01/01/202501/01/202401/01/202301/01/202201/01/202101/01/2020
Closing of the financial year31/12/202531/12/202431/12/202331/12/202231/12/202131/12/2020
Length of the financial year12 months12 months12 months12 months12 months12 months
Filing date08/07/202611/07/202504/07/202429/06/202315/07/202230/06/2021
General meeting03/06/202604/06/202505/06/202407/06/202301/06/202202/06/2021
Currency of the financial yearEUREUREUREUREUREUR
NBB quality labelSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controls

Financial ratios

Source · NBB

Looking for more information about this company?

Try for free

Annual accounts filings

Source · NBB, 20 filings
ModelClosingGeneral meetingFiledLanguageDocument
Abridged model31/12/202503/06/202608/07/2026FrenchPDF
Abridged model31/12/202404/06/202511/07/2025FrenchPDF
Abridged model31/12/202305/06/202404/07/2024FrenchPDF
Abridged model31/12/202207/06/202329/06/2023FrenchPDF
Abridged model31/12/202101/06/202215/07/2022FrenchPDF
Abridged model31/12/202002/06/202130/06/2021FrenchPDF
Abridged model31/12/201903/06/202013/07/2020FrenchPDF
Abridged model31/12/201805/06/201917/06/2019FrenchPDF
Abridged model31/12/201706/06/201816/07/2018FrenchPDF
Abridged model31/12/201607/06/201719/07/2017FrenchPDF
Abridged model31/12/201501/06/201601/08/2016FrenchPDF
Abridged model31/12/201403/06/201530/07/2015FrenchPDF
Abridged model31/12/201304/06/201417/07/2014FrenchPDF
Abridged model31/12/201205/06/201330/08/2013FrenchPDF
Abridged model31/12/201106/06/201230/08/2012FrenchPDF
Abridged model31/12/201001/06/201117/08/2011FrenchPDF
Abridged model31/12/200902/06/201025/08/2010FrenchPDF
Abridged model31/12/200803/06/200925/08/2009FrenchPDF
Abridged model31/12/200704/06/200818/08/2008FrenchPDF
Abridged model31/12/200606/06/200728/08/2007FrenchPDF

Indicative valuation

Order of magnitude

As an indication, this company is worth

between 0 € and 100 k€

The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.

Discover the Business plan
Disclaimer

Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.

Board of directors

Source · NBB, accounts to 31/12/2025

1 active · 11 ended

Active mandates

HG Pharma

Managing director · since 07 juillet 2023 · until 07 juillet 2029 · 0832.287.120

Represented by GILLES SMITS

Active

Ended mandates

JEAN-JACQUES SMITS

Managing director · since 07 juin 2023 · until 07 juin 2029

Ended
JEAN-JACQUES SMITS

Managing director · since 01 janvier 2017 · until 01 janvier 2023

Ended
HG Pharma

Managing director · since 01 janvier 2011 · until 01 janvier 2017 · 0832.287.120

Represented by GILLES SMITS

Ended
HG Pharma

Managing director · since 01 janvier 2011 · until 01 janvier 2017 · 0832.287.120

Represented by GILLES SMITS

Ended

Ownership and network

Looking for more information about this company?

Try for free

Belgian Official Gazette publications

Source · Belgian Official Gazette
  • Mandates12/12/2025
    SIEGE SOCIAL - DEMISSIONS, NOMINATIONS
    PDF
  • Other06/02/2024
    STATUTS (TRADUCTION, COORDINATION, AUTRES MODIFICATIONS, …)
    PDF
  • Mandates24/07/2023
    DEMISSIONS, NOMINATIONS
    PDF
  • Mandates02/06/2017
    DEMISSIONS, NOMINATIONS
    PDF
  • Mandates10/04/2017
    DEMISSIONS, NOMINATIONS
    PDF
  • Mandates01/04/2011
    DEMISSIONS, NOMINATIONS
    PDF
  • Mandates31/10/2005
    DEMISSIONS, NOMINATIONS
    PDF
  • Other30/12/2004
    RUBRIQUE CONSTITUTION (NOUVELLE PERSONNE MORALE, OUVERTURE SUCCURSALE, ETC...)
    PDF

Similar companies

A company's peers, by sector and size, are included in the Business plan.

See the Business plan

Timeline

  1. 2025
    Annual accounts 2025-159,3 k €↓
  2. 2024
    Annual accounts 2024115,4 k €↑
  3. 2023
    Annual accounts 2023-75,1 k €↓
  4. 2022
    Annual accounts 202251,7 k €↓
  5. 2021
    Annual accounts 2021158,4 k €↑
  6. 2020
    Annual accounts 2020131,5 k €↑
  7. 2019
    Annual accounts 2019116,7 k €↑
  8. 2018
    Annual accounts 2018-28,3 k €↓
  9. 2017
    Annual accounts 201794 k €↓
  10. 2016
    Annual accounts 2016135 k €↑
  11. 2015
    Annual accounts 201557 k €↓
  12. 2014
    Annual accounts 201484,9 k €↓
  13. 2013
    Annual accounts 2013123,2 k €↑
  14. 2012
    Annual accounts 2012-176,7 k €↓
  15. 2011
    Annual accounts 2011-175,7 k €↓
  16. 2010
    Annual accounts 2010-27,3 k €↑
  17. 2009
    Annual accounts 2009-47,6 k €↓
  18. 2008
    Annual accounts 2008-34,9 k €↑
  19. 2007
    Annual accounts 2007-38,4 k €↑
  20. 2006
    Annual accounts 2006-42,8 k €
  21. 17/12/2004
    IncorporationPublic limited company